SINGAPORE, Jan. 27, 2021 /PRNewswire/ -- Globally, about one in six deaths is due to cancer. With advances in treatment, early detection and treatment of cancer greatly improves survival rates of patients. And now, Toshiba's microRNA detection technologies is contributing to cancer detection at an ultra-early stage with accuracy, speed and cost efficiency by capturing very small amounts of microRNAs secreted by cancer cells into the blood.
[caption id="" align="aligncenter" width="600"] Koji Hashimoto, Senior Fellow, Nanomaterials and Frontier Research Laboratories, Toshiba Corporate Research and Development Center[/caption] [caption id="" align="aligncenter" width="600"] Detecting microRNAs that are increasingly secreted in cancer cells to determine whether cancer is present[/caption]
By PR Newswire